OREON Life Science Debuts Body-Specialized HA Filler at InterCHARM Korea 2025... "Contributing to the Global Competitiveness of K-Medical Aesthetics"
Medical aesthetics manufacturer OREON Life Science is participating in โInterCHARM Korea 2025,โ held at COEX in Seoul from July 2nd to 4th. The company plans to expand partnerships with domestic and international medical professionals and buyers by showcasing its major product lineup, including โiLEAD 70mL,โ a large-capacity HA filler specialized for body procedures.
OREON Life Science is a company specializing in the development and manufacturing of high-performance aesthetic solutions based on PLLA (Poly-L-Lactic Acid), PN (Polynucleotide), and HA (Hyaluronic Acid). It ensures stable quality through medical device manufacturing licenses and GMP certification. At this year's InterCHARM Korea, the company is highlighting the โiLEAD 70mLโ alongside its other key products.
According to the company, the large-capacity HA filler โiLEAD 70mLโ was developed to keep pace with the growing trend in body contouring and volume enhancement procedures. Designed with procedure efficiency and clinical management convenience in mind, it is expected to be a major point of interest for medical professionals at the event.
The OREON Life Science โiLEADโ series consists of GLOBAL, DEEP, ULTRA, and X lineups, offering a broad HA filler portfolio for precise treatments in areas such as the eyes, lips, forehead, nasolabial folds, and body. It is highly utilized by medical professionals for providing natural volume and stable retention after treatment.
At the exhibition, the company is also showcasing its full lineup of premium PLLA-based solutions that reflect global clinical demands and trends. The PLLA series includes: โฒโPLEJUV,โ a collagen stimulator; โฒโPiNkLLA,โ a bio-revitalizer; and โฒโPLORE,โ a biostimulator.
Additionally, โiยทNOVA,โ a high-performance skin rejuvenator in the i-Series lineup, is being featured. It is engineered with an optimal ratio of high and low-molecular weight HA and precisely blended with skin regeneration promoters such as amino acid complexes, succinic acid, glutathione, and niacinamide. The company expects it to be highly versatile for medical professionals, offering hydration, elasticity improvement, whitening, and antioxidant effects.
An OREON Life Science official stated, โThrough our participation in InterCHARM Korea, we plan to showcase the competitiveness of our high-performance aesthetic solutions to global medical professionals and actively pursue the expansion of global partnerships and new markets.โ They added, โWe will continue to contribute to enhancing the global competitiveness of K-medical aesthetics based on our differentiated technology, from ingredient design to clinical application.โ
๐ https://kr.aving.net/news/articleView.html?idxno=1801877ย
๐ https://www.yakup.com/news/index.html?mode=view&cat=12&nid=312495ย
ย
OREON Life Science Debuts Body-Specialized HA Filler at InterCHARM Korea 2025... "Contributing to the Global Competitiveness of K-Medical Aesthetics"
Medical aesthetics manufacturer OREON Life Science is participating in โInterCHARM Korea 2025,โ held at COEX in Seoul from July 2nd to 4th. The company plans to expand partnerships with domestic and international medical professionals and buyers by showcasing its major product lineup, including โiLEAD 70mL,โ a large-capacity HA filler specialized for body procedures.
OREON Life Science is a company specializing in the development and manufacturing of high-performance aesthetic solutions based on PLLA (Poly-L-Lactic Acid), PN (Polynucleotide), and HA (Hyaluronic Acid). It ensures stable quality through medical device manufacturing licenses and GMP certification. At this year's InterCHARM Korea, the company is highlighting the โiLEAD 70mLโ alongside its other key products.
According to the company, the large-capacity HA filler โiLEAD 70mLโ was developed to keep pace with the growing trend in body contouring and volume enhancement procedures. Designed with procedure efficiency and clinical management convenience in mind, it is expected to be a major point of interest for medical professionals at the event.
The OREON Life Science โiLEADโ series consists of GLOBAL, DEEP, ULTRA, and X lineups, offering a broad HA filler portfolio for precise treatments in areas such as the eyes, lips, forehead, nasolabial folds, and body. It is highly utilized by medical professionals for providing natural volume and stable retention after treatment.
At the exhibition, the company is also showcasing its full lineup of premium PLLA-based solutions that reflect global clinical demands and trends. The PLLA series includes: โฒโPLEJUV,โ a collagen stimulator; โฒโPiNkLLA,โ a bio-revitalizer; and โฒโPLORE,โ a biostimulator.
Additionally, โiยทNOVA,โ a high-performance skin rejuvenator in the i-Series lineup, is being featured. It is engineered with an optimal ratio of high and low-molecular weight HA and precisely blended with skin regeneration promoters such as amino acid complexes, succinic acid, glutathione, and niacinamide. The company expects it to be highly versatile for medical professionals, offering hydration, elasticity improvement, whitening, and antioxidant effects.
An OREON Life Science official stated, โThrough our participation in InterCHARM Korea, we plan to showcase the competitiveness of our high-performance aesthetic solutions to global medical professionals and actively pursue the expansion of global partnerships and new markets.โ They added, โWe will continue to contribute to enhancing the global competitiveness of K-medical aesthetics based on our differentiated technology, from ingredient design to clinical application.โ
๐ https://kr.aving.net/news/articleView.html?idxno=1801877ย
๐ https://www.yakup.com/news/index.html?mode=view&cat=12&nid=312495ย
ย